Reza Bavarsad Shahripour: A Practical Multimodal, Center-Specific Approach for Right-to-Left Shunt Detection in ESUS
Reza Bavarsad Shahripour, Associate Editor at Clinical Neuroimaging Journal, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Excited to share our recent work on comparing TCD, TTE, TEE, and cardiac CT in detecting right-to-left shunt in patients with ESUS.
Key takeaways:
- TCD is a highly sensitive, noninvasive tool – ideal for initial screening
- TEE provides the most reliable anatomical detail when confirmation is needed
- TTE remains a practical and widely available option
- Cardiac CT can be helpful in select cases but is not ideal as a standalone test
Overall, a stepwise, multimodal approach works best—starting with a sensitive screening tool and following with targeted confirmatory imaging.
Practical teaching point:
Instead of asking ‘which test is best?’, ask:
‘Which test works best in our center?’
The performance of these modalities depends heavily on local expertise, protocols, and workflow.
A strong neurosonology lab: TCD-first makes sense
Limited TCD access: TTE-first may be more practical
Complex cases: early TEE
The goal is to build a center-specific pathway that is efficient, reliable, and reproducible—not a one-size-fits-all algorithm.
Grateful to collaborate with an amazing team at UCSD and beyond.”
Title: Comparative Accuracy of TCD, TTE, TEE, and Cardiac CT in Detecting Right-to-Left Shunt in Embolic Stroke of Undetermined Source
Authors: Vikas Ravi, Yasaman Pirahanchi, Seyed Behnam Jazayeri, Emma Rice, Dawn Meyer, Kunal Agrawal, Royya Modir, Thomas Hemmen, Brett Meyer, Reza Bavarsad Shahripour
Read the Full Article on Neurology Clinical Practice

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons
-
Nov 18, 2026, 14:23Basanta Khatiwada: Advancing Haematology Through Research and Innovation at HAEMATOCON 2026
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: Towards Sustainable Anticoagulation
-
Nov 18, 2026, 13:33Breaking the Silence on Women and Girls with Bleeding Disorders – EHC
-
Nov 18, 2026, 13:32Maria Elisa Mancuso: Next-Generation Protein Therapies in Hemophilia
-
Nov 18, 2026, 13:25Maia Meier: Advocating for Women and Girls with Bleeding Disorders